Non-small cell lung cancer: clinical value of new biological predictors
- 1 June 1997
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 17, S37-S58
- https://doi.org/10.1016/s0169-5002(97)00639-9
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Expression of blood group antigen A by stage I non-small cell lung carcinomasThe Annals of Thoracic Surgery, 1995
- Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomasZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Prognostic significance of Ki67 labelling in resected non small cell lung cancerEuropean Journal Of Cancer, 1993
- Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- DNA polymerase-α as a putative early relapse marker in non-small cell lung cancer. An immunohistochemical studyCancer, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Blood group abh‐related antigens in normal and malignant bladder urothelium: Possible structural basis for the deletion of type‐2 chain abh antigens in invasive carcinomasInternational Journal of Cancer, 1989
- The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow upCancer, 1989
- Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Mutational Activation of the K-rasOncogeneNew England Journal of Medicine, 1987